Analyst Viewpoint
Increase in popularity of remote patient monitoring devices and technological advancements in the healthcare sector are fueling the mHealth market size. mHealth enables monitoring real-time patient information to track their heart rate, sugar levels, blood pressure, and other parameters. Rise in demand for remote patient monitoring devices for chronic diseases is driving the demand for mobile healthcare services.
Surge in adoption of digital health and easy availability of wearable fitness trackers is boosting market expansion. Increase in government initiatives to promote fitness awareness is likely to offer lucrative mHealth market opportunities. Leading companies in the sector are launching new applications with advanced technologies to meet patient demands. Moreover, manufacturers are investing in research and development activities to analyze the requirements of physicians and develop relevant services accordingly.
mHealth or mobile health is a general term for the use of mobile phones and other wireless technology in medical care. mHealth is used to improve health outcomes, research, and healthcare services to enhance patient care. These are available in devices, connections, applications, and service forms. mHealth plays a crucial part in telemedicine by increasing patient interaction and enabling remote data access to healthcare providers.
Digital health is on the rise across the globe due to the availability of advanced technologies and accessibility to modern healthcare services. mHealth enables mobile self-care services for patients suffering from diabetes, chronic diseases, and other health issues. The technology simplifies interaction among patients and allows physicians to access real-time patient data, such as sugar level, blood pressure, and heart rate.
Remote patient monitoring devices are extensively utilized by healthcare professionals to track patient information and change the treatment mode as per the requirements. Mobile healthcare devices are employed to monitor patient data where patients can update their details at their end. These devices help provide better treatment, increase patient engagement, reduce patient visits to the hospitals, decrease healthcare costs, and keep patient data updated. Thus, increase in popularity of advanced remote patient monitoring devices is fueling mHealth market value.
Rise in demand for remote patient monitoring solutions for chronic conditions is bolstering the market statistics. Chronic conditions, such as diabetes, cancer, and heart disease require regular patient data monitoring to avoid severe issues and disabilities. mHealth allows patients to register their blood sugar levels, heart rate, and other symptoms through remote devices. Hence, increase in prevalence of chronic conditions is driving market revenue.
According to the American Hospital Association, around 133 million Americans, nearly half the population, suffer from at least one chronic condition, such as arthritis, hypertension, or heart disease. The number is estimated to reach approximately 170 million by 2030.
Increase in penetration of 5G connectivity, artificial intelligence, machine learning, and augmented reality are some of the trending technologies adopted by the healthcare sector. Incorporation of Internet of Things (IoT) in mHealth enhances connectivity and accessibility through remote networks. Leading companies in the market are investing heavily to develop advanced mobile health apps for diabetes management, which in turn is fueling market progress. For instance, AT&T collaborated with Smart Meter to develop advanced digital health solutions for monitoring and tracking chronic ailments, such as diabetes, using Smart Meter’s IoT devices and AT&T’s well-established IoT network.
Rise in demand for wearable fitness trackers for heart rate monitoring is boosting market dynamics. Manufacturers are employing motion detectors, temperature monitors, and sensors to precisely record patient data. People are keen on using wearable fitness trackers due to its high efficiency, accuracy, easy availability, and feasibility.
According to the regional mHealth market analysis, North America dominated the global landscape in 2022. Implementation of government initiatives to promote mHealth is likely to propel the mHealth industry share during the forecast period. For instance, the U.S. Department of Health and Human Services, the National Institutes of Health, and the National Cancer Institute initiated Smokefree.gov and BeTobaccoFree.gov, to spread awareness among the population. Leading companies in the region are adopting the latest technologies to introduce new applications and services for patients.
Increase in use of connected devices and mHealth applications to manage chronic conditions is fueling market growth. Availability of strong network connectivity and developed healthcare infrastructure is favoring market conditions in the region. Moreover, easy accessibility to advanced technologies allows companies to develop services according to patient requirements.
Leading companies in the market are focusing on adopting the latest technologies to meet recent mHealth market trends. They are incorporating IoT, artificial intelligence, motion sensors, and temperature trackers into wearable fitness trackers to monitor real-time patient data. Manufacturers are introducing new applications and services to increase patient engagement and enhance their fitness awareness.
Some of the key players in the industry are Dexcom, Inc., Apple, Inc., FitBit, Inc., Withings, Proteus Digital Health, Inc., Omada Health, Inc., Welldoc, Inc., Teladoc Health, Inc., Noom, Inc., Propeller Health, Canary Health, BiogeniQ Inc., Glooko, Inc., Firstbeat Technologies, and BioTelemetry, Inc.
These companies have been profiled in the mHealth market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 97.0 Bn |
| Market Forecast (Value) in 2031 | US$ 353.4 Bn |
| Growth Rate (CAGR) | 15.3% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Tons | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 97.0 Bn in 2022
It is projected to register a CAGR of 15.3% from 2023 to 2031
Increase in popularity of remote patient monitoring devices, and growth in technological advancements in the healthcare sector
North America was the most lucrative region in 2022
Dexcom, Inc., Apple, Inc., FitBit, Inc., Withings, Proteus Digital Health, Inc., Omada Health, Inc., Welldoc, Inc., Teladoc Health, Inc., Noom, Inc., Propeller Health, Canary Health, BiogeniQ Inc., Glooko, Inc., Firstbeat Technologies, and BioTelemetry, Inc.
1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global mHealth Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global mHealth Market Analysis and Forecasts, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. COVID-19 Pandemic Impact on Industry
6. mHealth Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Connected Medical Devices
6.3.1.1. Heart Rate Monitors
6.3.1.2. Activity Monitors
6.3.1.3. Electrocardiograph
6.3.1.4. Fetal Monitoring
6.3.1.5. Neuromonitoring
6.3.1.6. Others
6.3.2. mHealth Applications
6.3.2.1. Fitness & Wellness
6.3.2.2. Diabetes
6.3.2.3. Cardiovascular Diseases
6.3.2.4. Central Nervous System Diseases
6.3.2.5. Respiratory Diseases
6.3.2.6. Musculoskeletal Diseases
6.3.2.7. Smoking Cessation
6.3.2.8. Medication Adherence
6.3.2.9. Others
6.3.3. mHealth Services
6.4. Market Attractiveness, by Product
7. Global mHealth Market Analysis and Forecast, by End-user
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. B2B
7.3.1.1. Patients
7.3.1.2. Caregivers
7.3.2. B2C
7.3.2.1. Providers
7.3.2.2. Payers
7.3.2.3. Employers
7.3.2.4. Others
7.4. Market Attractiveness, by End-user
8. Global mHealth Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Region
9. North America mHealth Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2031
9.2.1. Connected Medical Devices
9.2.1.1. Heart Rate Monitors
9.2.1.2. Activity Monitors
9.2.1.3. Electrocardiograph
9.2.1.4. Fetal Monitoring
9.2.1.5. Neuromonitoring
9.2.1.6. Others
9.2.2. mHealth Applications
9.2.2.1. Fitness & Wellness
9.2.2.2. Diabetes
9.2.2.3. Cardiovascular Diseases
9.2.2.4. Central Nervous System Diseases
9.2.2.5. Respiratory Diseases
9.2.2.6. Musculoskeletal Diseases
9.2.2.7. Smoking Cessation
9.2.2.8. Medication Adherence
9.2.2.9. Others
9.2.3. mHealth Services
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. B2B
9.3.1.1. Patients
9.3.1.2. Caregivers
9.3.2. B2C
9.3.2.1. Providers
9.3.2.2. Payers
9.3.2.3. Employers
9.3.2.4. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe mHealth Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Connected Medical Devices
10.2.1.1. Heart Rate Monitors
10.2.1.2. Activity Monitors
10.2.1.3. Electrocardiograph
10.2.1.4. Fetal Monitoring
10.2.1.5. Neuromonitoring
10.2.1.6. Others
10.2.2. mHealth Applications
10.2.2.1. Fitness & Wellness
10.2.2.2. Diabetes
10.2.2.3. Cardiovascular Diseases
10.2.2.4. Central Nervous System Diseases
10.2.2.5. Respiratory Diseases
10.2.2.6. Musculoskeletal Diseases
10.2.2.7. Smoking Cessation
10.2.2.8. Medication Adherence
10.2.2.9. Others
10.2.3. mHealth Services
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. B2B
10.3.1.1. Patients
10.3.1.2. Caregivers
10.3.2. B2C
10.3.2.1. Providers
10.3.2.2. Payers
10.3.2.3. Employers
10.3.2.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific mHealth Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Connected Medical Devices
11.2.1.1. Heart Rate Monitors
11.2.1.2. Activity Monitors
11.2.1.3. Electrocardiograph
11.2.1.4. Fetal Monitoring
11.2.1.5. Neuromonitoring
11.2.1.6. Others
11.2.2. mHealth Applications
11.2.2.1. Fitness & Wellness
11.2.2.2. Diabetes
11.2.2.3. Cardiovascular Diseases
11.2.2.4. Central Nervous System Diseases
11.2.2.5. Respiratory Diseases
11.2.2.6. Musculoskeletal Diseases
11.2.2.7. Smoking Cessation
11.2.2.8. Medication Adherence
11.2.2.9. Others
11.2.3. mHealth Services
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. B2B
11.3.1.1. Patients
11.3.1.2. Caregivers
11.3.2. B2C
11.3.2.1. Providers
11.3.2.2. Payers
11.3.2.3. Employers
11.3.2.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America mHealth Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Connected Medical Devices
12.2.1.1. Heart Rate Monitors
12.2.1.2. Activity Monitors
12.2.1.3. Electrocardiograph
12.2.1.4. Fetal Monitoring
12.2.1.5. Neuromonitoring
12.2.1.6. Others
12.2.2. mHealth Applications
12.2.2.1. Fitness & Wellness
12.2.2.2. Diabetes
12.2.2.3. Cardiovascular Diseases
12.2.2.4. Central Nervous System Diseases
12.2.2.5. Respiratory Diseases
12.2.2.6. Musculoskeletal Diseases
12.2.2.7. Smoking Cessation
12.2.2.8. Medication Adherence
12.2.2.9. Others
12.2.3. mHealth Services
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. B2B
12.3.1.1. Patients
12.3.1.2. Caregivers
12.3.2. B2C
12.3.2.1. Providers
12.3.2.2. Payers
12.3.2.3. Employers
12.3.2.4. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa mHealth Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Connected Medical Devices
13.2.1.1. Heart Rate Monitors
13.2.1.2. Activity Monitors
13.2.1.3. Electrocardiograph
13.2.1.4. Fetal Monitoring
13.2.1.5. Neuromonitoring
13.2.1.6. Others
13.2.2. mHealth Applications
13.2.2.1. Fitness & Wellness
13.2.2.2. Diabetes
13.2.2.3. Cardiovascular Diseases
13.2.2.4. Central Nervous System Diseases
13.2.2.5. Respiratory Diseases
13.2.2.6. Musculoskeletal Diseases
13.2.2.7. Smoking Cessation
13.2.2.8. Medication Adherence
13.2.2.9. Others
13.2.3. mHealth Services
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. B2B
13.3.1.1. Patients
13.3.1.2. Caregivers
13.3.2. B2C
13.3.2.1. Providers
13.3.2.2. Payers
13.3.2.3. Employers
13.3.2.4. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Dexcom, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Apple, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. FitBit, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Withings
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Proteus Digital Health, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Omada Health, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Welldoc, Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Teladoc Health, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Noom, Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Propeller Health.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Canary Health
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. BiogeniQ Inc.
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Product Portfolio
14.3.12.3. Financial Overview
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. Glooko, Inc.
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Product Portfolio
14.3.13.3. Financial Overview
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
14.3.14. Firstbeat Technologies
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Product Portfolio
14.3.14.3. Financial Overview
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview
14.3.15. BioTelemetry, Inc.
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Product Portfolio
14.3.15.3. Financial Overview
14.3.15.4. SWOT Analysis
14.3.15.5. Strategic Overview
List of Tables
Table 01: Global mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global mHealth Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 03: Global mHealth Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America mHealth Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 05: North America mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 06: North America mHealth Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 07: Europe mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: Europe mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 09: Europe mHealth Market Value (US$ Mn) Forecast, by End-user 2017–2031
Table 10: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 12: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Latin America mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Latin America mHealth Market Value (US$ Mn) Forecast, by End-user 2017–2031
Table 16: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 18: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by End-user 2017–2031
List of Figures
Figure 01: Global mHealth Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global mHealth Market Value Share, by Product, 2022
Figure 03: Global mHealth Market Value Share, by End-user, 2022
Figure 04: Global mHealth Market Value Share Analysis, by Product, 2022 and 2031
Figure 05: Global mHealth Market Attractiveness Analysis, by Product, 2023–2031
Figure 06: Global mHealth Market Value Share Analysis, by End-user, 2022 and 2031
Figure 07: Global mHealth Market Attractiveness Analysis, by End-user 2023–2031
Figure 08: Global mHealth Market Value Share Analysis, by Region, 2022 and 2031
Figure 09: Global mHealth Market Attractiveness Analysis, by Region, 2023–2031
Figure 10: North America mHealth Market Value (US$ Mn) Forecast, 2017–2031
Figure 11: North America mHealth Market Value Share Analysis, by Country, 2022 and 2031
Figure 12: North America mHealth Market Attractiveness Analysis, by Country, 2023–2031
Figure 13: North America mHealth Market Value Share Analysis, by Product, 2022 and 2031
Figure 14: North America mHealth Market Attractiveness Analysis, by Product, 2023–2031
Figure 15: North America mHealth Market Value Share Analysis, by End-user, 2022 and 2031
Figure 16: North America mHealth Market Attractiveness Analysis, by End-user 2023–2031
Figure 17: Europe mHealth Market Value (US$ Mn) Forecast, 2017–2031
Figure 18: Europe mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 19: Europe mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 20: Europe mHealth Market Value Share Analysis, by Product, 2022 and 2031
Figure 21: Europe America mHealth Market Attractiveness Analysis, by Product, 2023–2031
Figure 22: Europe mHealth Market Value Share Analysis, by End-user, 2022 and 2031
Figure 23: Europe mHealth Market Attractiveness Analysis, by End-user 2023–2031
Figure 24: Asia Pacific mHealth Market Value (US$ Mn) Forecast, 2017–2031
Figure 25: Asia Pacific mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 26: Asia Pacific mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 27: Asia Pacific mHealth Market Value Share Analysis, by Product, 2022 and 2031
Figure 28: Asia Pacific America mHealth Market Attractiveness Analysis, by Product, 2023–2031
Figure 29: Asia Pacific mHealth Market Value Share Analysis, by End-user, 2022 and 2031
Figure 30: Asia Pacific mHealth Market Attractiveness Analysis, by End-user 2023–2031
Figure 31: Latin America mHealth Market Value (US$ Mn) Forecast, 2017–2031
Figure 32: Latin America mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 33: Latin America mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 34: Latin America mHealth Market Value Share Analysis, by Product, 2022 and 2031
Figure 35: Latin America mHealth Market Attractiveness Analysis, by Product, 2023–2031
Figure 36: Middle East & Africa mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 37: Middle East & Africa mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Middle East & Africa America mHealth Market Value Share Analysis, by Product, 2022 and 2031
Figure 39: Middle East & Africa America mHealth Market Attractiveness Analysis, by Product, 2023–2031
Figure 40: Middle East & Africa mHealth Market Value Share Analysis, by End-user, 2022 and 2031
Figure 41: Middle East & Africa mHealth Market Attractiveness Analysis, by End-user 2023–2031
Figure 42: Global mHealth Market Share Analysis, by Company (2022)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
mHealth Market
*86 figures and 60 tables includes